Clinical Trial Update: Leflunomide in Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

A Phase 2 trial of Leflunomide for systemic lupus erythematosus (SLE) sponsored by Sanofi has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Leflunomide (Arava) (leflunomide)

Snippet

Sponsor: Sanofi | Conditions: Systemic Lupus Eythematosus (SLE) | Phase 2 | Status: COMPLETED